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Abstract
Acute gastroenteritis (AGE) is a common illness affecting all age groups worldwide, causing an estimated three million
deaths annually. Viruses such as rotavirus, adenovirus, and caliciviruses are a major cause of AGE, but in many patients a
causal agent cannot be found despite extensive diagnostic testing. Proposing that novel viruses are the reason for this
diagnostic gap, we used molecular screening to investigate a cluster of undiagnosed cases that were part of a larger case
control study into the etiology of pediatric AGE. Degenerate oligonucleotide primed (DOP) PCR was used to non-specifically
amplify viral DNA from fecal specimens. The amplified DNA was then cloned and sequenced for analysis. A novel virus was
detected. Elucidation and analysis of the genome indicates it is a member of the Bocavirus genus of the Parvovirinae, 23%
variant at the nucleotide level from its closest formally recognized relative, the Human Bocavirus (HBoV), and similar to the
very recently proposed second species of Bocavirus (HBoV2). Fecal samples collected from case control pairs during 2001 for
the AGE study were tested with a bocavirus-specific PCR, and HBoV2 (sequence confirmed) was detected in 32 of 186 cases
with AGE (prevalence 17.2%) compared with only 15 controls (8.1%). In this same group of children, HBoV2 prevalence was
exceeded only by rotavirus (39.2%) and astrovirus (21.5%) and was more prevalent than norovirus genogroup 2 (13.4%) and
adenovirus (4.8%). In a univariate analysis of the matched pairs (McNemar’s Test), the odds ratio for the association of AGE
with HBoV2 infection was 2.6 (95% confidence interval 1.2–5.7); P=0.007. During the course of this screening, a second
novel bocavirus was detected which we have designated HBoV species 3 (HBoV3). The prevalence of HBoV3 was low (2.7%),
and it was not associated with AGE. HBoV2 and HBoV3 are newly discovered bocaviruses, of which HBoV2 is the thirdmost-
prevalent virus, after rotavirus and astrovirus, associated with pediatric AGE in this study.
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Introduction
Acute gastroenteritis (AGE) is a common illness affecting all age
groups worldwide. Even in developed countries, most of the
population will average one episode of AGE per year [1]. Among
young children and the elderly, the rate is higher and the disease
more severe [2,3]. Globally, approximately 1.5 billion episodes
and 1.5 to 2.5 million deaths annually in children under age five
are estimated to be associated with AGE, the majority occurring in
developing countries [4]. Among the elderly, underlying immu-
nological, physiological and functional deterioration exacerbate
severity, resulting in increased morbidity and mortality attributed
to diarrheal disease. Mortality may exceed 50% in the above 73
years age group in the US [3]. However, for such an important
disease, our understanding of causality remains incomplete. The
importance of bacteria and parasites in AGE has been known for
many years, although the roles of campylobacter (1972) [5] and
cryptosporidium (1976) [6] in human infection were recognized
more recently. Viruses such as rotavirus and enteric adenovirus
were also first described over 30 years ago and shown to have an
association with diarrheal disease. Rotavirus is the most common
cause of viral AGE in children under age five [7]. The recent
widespread availability of molecular diagnostics has allowed an
increased understanding of the role of other viruses in causing
AGE. The human calicivirus genus Norovirus (NoV, formerly
Norwalk-like virus, NLV) is now recognized as the most common
cause of epidemic outbreaks of AGE across all age groups [1] with
noroviruses belonging to genogroup 2 (NoV GII) more frequent
than those belonging to genogroup 1 (NoV GI). Recent reports
suggest prevalence rates of 9 to 20% for NoV in sporadic AGE in
children [8–11]. Similarly, associations with AGE have also been
made for both a second calicivirus genus Sapovirus (formerly
Sapporo-like virus, SLV or classic calicivirus) and astrovirus. A
limited number of reports suggest sapoviruses are less frequently
found in cases of AGE than NoVs, are mainly restricted to
children less than age five years and may cause less severe
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Human astroviruses are reported to have an association with
AGE, especially in children, with prevalence rates up to 8.6%
documented [15–17]. Higher rates (39%) have been reported in
children less than 1 year old [18] and in areas lacking adequate
sanitation [19]. Other viruses such as torovirus, picobirnavirus,
picotrinavirus, pestivirus and coronavirus have also been impli-
cated [20–23]. Lately, there have been reports of human bocavirus
(HBoV) sequences in feces of children with respiratory infections
or AGE [24–26]. However, many of these observations are from
uncontrolled trials and in the absence of large prospective
controlled studies, their association with AGE is uncertain.
Despite this wide range of known and suspected pathogens, in
both pediatric and adult populations, the pathogen causing AGE
remains unidentified in up to 67% of cases [7,14,27,28].
In order to further investigate the causes of AGE in children, in
late 2000 we commenced a prospective controlled study of patients
presenting to a children’s hospital in Adelaide, South Australia.
Unexpectedly, even with extensive molecular testing, we could not
find a cause in 28% of cases (Ratcliff, R.M. unpublished).
Proposing that novel viruses may be the cause of the undiagnosed
cases, we developed a method for ‘non-selective’ detection of viral
DNA in feces. This method uses degenerate oligonucleotide
primed (DOP) PCR amplification [29] to non-specifically amplify
DNA from diarrheal samples. Previously, DOP amplification had
been utilized to replicate DNA from minute samples such as single
cell nuclei, and forensic and archaeological sources [29]. An
alternative ‘non-specific’ amplification method used nuclease
digestion to specifically purify virus nucleic acid by exploiting
the protection of the virus nucleic acid from digestion afforded by
the virus capsid [30]. Combining nuclease digestion with DOP
amplification ought to facilitate the sole replication of viral nucleic
acid from nucleic acid ‘soups’ such as feces. The DNA produced
from such virus enrichment followed by non-specific amplification
can be cloned and sequenced to assess the presence of viral DNA
and provide a method to screen for novel enteric viruses. We
initially investigated a ‘summer’ cluster of sporadic AGE cases
occurring between January and April 2001 and who were part of
the case control study into the etiology of pediatric AGE. We
detected a previously unknown parvovirus, which we have named
Human Bocavirus species 2 (HBoV2). Following the development
of specific amplification assays to detect HBoV2, we screened all
samples collected from cases and controls in the study during 2001
and assessed their association with pediatric AGE. During this
screening, we discovered a second novel parvovirus which we have
named Human Bocavirus species 3 (HBoV3).
Results
Routine screening for known causal agents
Samples from 197 cases and 197 aged-matched controls were
available for analysis. A bacterial pathogen was isolated in only
9 patients in the first sample tested, with one additional
salmonella isolate and one yersinia isolated in second samples
from another two patients. In total, only 11 patients had
bacterial pathogens identified. No bacterial testing was done on
the controls. A ‘known’ viral pathogen (NoV GI, NoV GII,
sapovirus, astrovirus, rotavirus or adenovirus) was found in first
or second specimens in 125/197 (63.5%) of cases and in 49/197
(24.9%) of controls. Overall a ‘known’ viral or bacterial
pathogen was found in 134/197 (68.0%) of cases (2 salmonella
positive cases were also rotavirus infected, one of whom also had
adenovirus). Therefore 32% of AGE cases remained without a
diagnosis.
Discovery of novel virus sequence
In February 2001, a 9 month old male presenting with coryza,
fever, vomiting and diarrhea was enrolled in the case control study
and fecal samples collected at the time of presentation (W153) and
3 days later (W154). No microbial or virological agent associated
with AGE was initially detected in either sample despite extensive
testing. As one of a number of ‘pathogen negative’ samples being
screened, the viral nucleic acid fraction of the fecal suspension was
prepared, DOP amplified and products examined by cloning and
sequencing. A total of 43 PCR products were sequenced from the
initial sample (W153) and GenBank homology searching
(tBLASTx) indicated 38 showed between 46% and 91% amino
acid homology to the human bocavirus (HBoV). A further 31 PCR
products derived from sample W154 were sequenced and 24
showed amino acid homology of between 42% and 91% to HBoV.
The remaining sequences showed no evidence of significant
homology to known viruses.
Using the HBoV strain st2 (GenBank DQ000496) as a
reference, the 55 DOP-generated sequences were aligned and
many overlapped to form a discontinuous sequence of approxi-
mately 3300 nucleotides of the new virus genome (.60%) that
appeared to lack at least 1000 and 750 nucleotides from the left
and right ends of the genome respectively. PCR primers
homologous to the DOP-generated sequences were designed to
amplify and sequence products from sample W153 to span the
sequence gaps and similarly the semi-DOP PCR approach was
employed to extend the virus sequence in both up and
downstream directions. For sequence confirmation and to remove
potential errors generated during the DOP amplification, the
sequence was rederived using primers homologous to the DOP-
generated sequence in a series of specific PCR reactions to amplify
and sequence overlapping products directly from sample W153.
Each nucleotide was confirmed by a minimum of two sequences
from separate PCR reactions for all 5204 nucleotides of the
sequence. The sequence of similarly generated product from the
second sample from the same patient, W154, was homologous to
W153 sequence.
Author Summary
Acute gastroenteritis (AGE) is a common illness affecting
all age groups worldwide, causing an estimated three
million deaths annually. However, in many patients a
causal agent cannot be found despite extensive diagnostic
testing. Proposing that novel viruses are the reason for this
diagnostic gap, we screened fecal samples from symp-
tomatic children using a molecular degenerate amplifica-
tion technique and detected the presence of a novel
parvovirus, Human Bocavirus species 2 (HBoV2). The
genome of HBoV2 is 23% variant from its closest relative,
the human bocavirus, a member of the Bocavirus genus of
the Parvovirinae. Using specific amplification assays, we
then found HBoV2 was the thirdmost-prevalent virus
detected in samples from symptomatic children in a case
control study of AGE. Further, we found virus presence was
associated with symptoms. During this screening, we
detected a second related parvovirus, which we have
named Human Bocavirus species 3 (HBoV3), but the
prevalence was low and not associated with symptoms.
The discovery of HBoV2 has reduced the diagnostic gap,
but more studies are required to further investigate its role
in AGE.
A Novel Bocavirus Associated with Gastroenteritis
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Homology alignments with selected members of the Parvovir-
inae, including all members of the genus Bocavirus (bovine
parvovirus 1, minute virus of canines and HBoV), confirm that
W153 is a member of the Bocavirus genus of the Parvovirinae
(Figure 1). From this alignment we predict that the W153 sequence
spans the entire coding region of the virus genome but lacks up to
100 nucleotides of both terminal regions. At the nucleotide level
the W153 sequence is 23% variant from its closest relative, the
HBoV but contains open reading frames (ORFs) for NS1, NP1,
VP1 and VP2 proteins in a similar arrangement to the HBoV
including the alignment of the NP1 ORF in an alternate reading
frame to VP1 whereby it overlaps the start of the VP1 by 13
nucleotides (Figure 2). A comparison of the length of the coding
regions, and the genetic distance (percent dissimilarity) between
them, for W153 and HBoV at the nucleotide and amino acid level
are presented in Table 1. These results are in contrast to strains of
the HBoV where the homology between all strains exceeds 98% at
both nucleotide and amino acid level for all ORFs [24,31]. The
ICTVb criteria for defining a new species in the bocavirus genus is
a non-structural gene genetic homology of less than 95% (C.
Bu ¨chen-Osmond, International Committee on Taxonomy of
Viruses, http://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/fs_parvo.
htm, Columbia University, New York, USA). Thus we propose
that the virus detected in sample W153 is not a new strain of the
HBoV but rather a new species of Bocavirus (family Parvoviridae
subfamily Parvovirinae) and have assigned the name Human
Bocavirus species 2 (HBoV2; see Discussion and reference 35 for
further details). The sequence of the HBoV2-W153 strain has been
deposited in GenBank (designated HBoV2-W153, accession
number EU082213).
Discovery of a second novel bocavirus while assessing
the prevalence of HBoV2 in children
To examine whether HBoV2 was associated with AGE we used
the nested consensus PCR assay to screen fecal samples from the
197 matched case-control pairs, confirming all positives by
sequencing. The sequence analysis showed the presence of both
HBoV2 and HBoV, as well as another novel parvovirus. The
genome of this virus from sample W471 was sequenced using
specific PCRs incorporating primers homologous to recovered
W471 sequence and homologous regions in an alignment of
HBoV2-W153 and HBoV, plus a semi-DOP approach similar to
that used for HBoV2-W153 to extend the sequence, to recover
5242 nucleotides of sequence spanning the entire coding region,
but missing the termini sequences as for HBoV2-W153. The
alignment of the W471 sequence with other Parvovirinae confirms
it is also a bocavirus (Figure 1) with the genetic distance of the
ORFs at both nucleotide and amino acid level (Table 1) indicative
it is a novel bocavirus species. To the virus in sample W471, we
Figure 1. Phylogenetic analysis of parvoviruses: Maximum likelihood dendrogram (bootstrapped, 1,000 replicates) based on full-
length parvovirus genome sequence (nucleotide) alignments. Approximately 100–200 nucleotides are absent from each termini of the
HBoV2, HBoV3, and HBoV sequences.
doi:10.1371/journal.ppat.1000391.g001
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GenBank EU918736). The unusual pattern of similarity for
HBoV3 seen in Table 1 (genetically closer to HBoV in the non-
structural protein-encoding regions but to HBoV2 in the structural
protein-encoding region) suggests that HBoV3 might be the result
of an ancestral recombination event between HBoV and HBoV2.
To investigate this possibility a similarity analysis (Simplot) was
performed comparing HBoV3 with HBoV and HBov2. This
confirmed that two recombination sites are present, immediately
upstream of both NS1 and VP1/2 ORFs (Figure 3).
Virus prevalence in children
The analysis of virus prevalence in samples collected during
2001 is presented in Table 2. Since bacterial isolation was only
performed on cases we have excluded from the statistical analysis
the 11 cases with bacterial pathogens (of which one was HBoV2
positive, one HBoV2 and astrovirus, one astrovirus and adeno-
virus and one HBoV) and their associated 11 controls (of which 3
were HBoV2 positive, one HBoV2 plus HBoV and one astrovirus
positive). Thus 186 matched case control pairs were used for the
statistical analysis of the association of viruses with disease. The
Figure 2. The HBoV2 and HBoV3 genomes. Diagrammatic representation of HBoV2 (HBoV2-W153, 5204 nucleotides) and HBoV3 (HBoV3-W471,
5242 nucleotides) sequence showing the position of open reading frames for NS1, NP1, VP1, and VP2, compared with other bocaviruses: bovine
parvovirus 1 (BPV 1), minute virus of canines (MVC), and human bocavirus (HBoV). For both HBoV2 and HBoV3, as with HBoV, the NP1 gene is in an
alternate reading frame to VP1 and overlaps the start of VP1 by 13 nucleotides. Similarly, VP2 is collinear to VP1 and results from initiation of
translation at a downstream ATG and co-terminates.
doi:10.1371/journal.ppat.1000391.g002
Table 1. Comparison of the open reading frames for HBoV2-W153, HBoV2-W208, HBoV3-W471, and HBoV st1.
Virus or Strain NS1 NP1 VP1 VP2
Amino acids* HBoV2 641 216 668 539
HBoV3 662 219 669 540
HBoV 640 220 672 543
Pairwise dissimilarity
{ HBoV2-W153 to HBoV2-W208 0.05 (0) 0.3 (0) 0.05 (0) 0.06 (0)
HBoV2-W153 to HBoV st1 25.8 (22.4) 22.7 (29.8) 21.2 (19.3) 23.1 (21.6)
HBoV2-W153 to HBoV3-W471 24.2 (23.1) 21.2 (29.7) 12.3 (9.0) 14.2 (10.4)
HBoV3-W471 to HBoV st1 12.7 (8.9) 13.2 (16.5) 23.3 (19.5) 24.6 (21.7)
*Number of amino acids encoded for each protein.
{Pairwise percent dissimilarity at both the nucleotide and amino acid (parentheses) levels.
doi:10.1371/journal.ppat.1000391.t001
A Novel Bocavirus Associated with Gastroenteritis
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range 1 day to 17.6 years. One hundred and twenty-two of the
cases were male. The mean age of the controls was 2.6 years,
median 1.8 years, age range 1 day to 16.5 years. One hundred and
twenty two of the controls were male.
Only one sample was collected from each control whereas 105
of the 186 cases had a second sample collected within 3 days. Thus
the univariant analysis of matched case control pairs was
performed with and without the inclusion of the second sample
from cases. When including only a single (first) sample from each
case, the univariant analysis showed an association between
infection and AGE only for rotavirus, which was also the most
prevalent virus detected (Table 2). When including the second case
samples in the analysis, an association between infection and AGE
was additionally found for HBoV2, adenovirus and astrovirus.
Because of the high frequency of multiple viruses detected in
samples from cases (51, 27.4%) and controls (15, 8%), a
multivariate conditional logistic regression analysis was performed
on the pooled case data using all detections which had an
association P,0.2 in univariate analysis (Table 3). In this analysis,
an association between infection and AGE was also found for NoV
GII in addition to those associated in the pooled univariant
analysis; rotavirus, HBoV2, adenovirus and astrovirus.
In the complete data set, samples from the 197 case control
pairs, a pathogen could not be detected in 63 of cases (32.0%)
prior to screening for HBoV2. HBoV2 was detected in 11 of these
‘pathogen negative’ cases, a reduction of cases to 52 (26.4%) which
represents a 17.5% reduction in the diagnostic gap in this data set.
Although we originally targeted a ‘summer’ peak of AGE cases
to screen for the presence of novel viruses, HBoV2 was detected
throughout 2001, predominantly between January and mid-
September (in the Southern Hemisphere, mid-summer to early
spring).
Sequence analysis of bocavirus strains: partial NS1
sequence
The partial NS1 sequences from all HBoV, HBoV2 and
HBoV3 strains detected during this study were aligned and
phylogenetically compared (Figure 4). All show a high degree of
nucleotide conservation within each of the three clades HBoV,
HBoV2 and HBoV3, similar to the recent observations for HBoV
[24,31]. The virus sequence from sample W208, designated
HBoV2-W208, was extended using the same primer sets as used to
rederive HBoV2-W153, to recover 5156 nucleotides (99.9%
similar to HBoV2-W153) encompassing the complete encoding
region but also missing the termini (GenBank accession
EU082214).
Detection of HBoV in diarrhea
Recently, there has been reports of detecting HBoV sequences
in feces associated with respiratory infections, or AGE, in children
[24,26]. Although these observations are largely from uncontrolled
specimens, we assessed the prevalence of HBoV in our data from
matched case control pairs. In addition, samples were also
screened using PCR incorporating published HBoV primers
[32] but no additional positives were detected. In total, HBoV
was detected in 17 case samples (9.1%) compared with 11 controls
(5.9%). HBoV was not statistically associated with AGE.
Discussion
This study reports the discovery of two new parvoviruses,
HBoV2 and HBoV3. Based on a comparison with other species,
the 5204 and 5242 nucleotide sequences recovered for these virus
respectively, represents over 98% of the predicted genome for both
viruses, each containing the ORFs typical of other bocaviruses and
only lacking both termini. Our initial attempts to sequence the
Figure 3. Genome similarity plot of HBoV3-W471 against HBoV (black line, DQ000495) and HBoV2-W153 (grey line) showing
percentage similarity along the aligned genomes (SimPlot 3.2, 2-parameter (Kimura) distance model, window size is 300 bp, step
size is 30 bp). Approximate recombination sites are indicated by the crossover of the sequence most similar to HBoV3-W471 at positions 200 and
3,000 nucleotides, just upstream of NS1 and VP1/2 ORFs; highlighted by the two arrows. Note the high level of conservation between all three
genomes toward the 39 terminus of NS1 and the 59 terminus of VP1/2 ORFs, presumably the result of functional constraint.
doi:10.1371/journal.ppat.1000391.g003
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the terminal regions of HBoV are problematic [32], most likely
due to hairpin loop structures as identified at the termini of other
parvoviruses [33]. Work to clarify the sequence of the viral termini
is ongoing. Genetic homology alignments place both HBoV2 and
HBoV3 in the Bocavirus genus of the Parvovirinae (Figure 1) and
both have a similar genome arrangement of putative ORFs to
HBoV. HBoV2 is 23% variant from HBoV, its closest previously
known relative. HBoV3 lies between the two, 18% variant both
from HBoV2 and HBoV at the genome level. The level of
dissimilarity to HBoV is maintained for HBoV2 across the coding
regions at both nucleotide and amino acid levels. Intriguingly, this
is not the case for HBoV3, where the non-structural ORFs NS1
and NP1 are more similar to HBoV, where as the structural ORF
(VP1/VP2) is more similar to HBoV2 (Table 1). Thus HBoV3
may be the consequence of a recombination event between
ancestral forms of HBoV2 and HBoV. The SimPlot analysis on an
alignment of the three viral genomes (Figure 3) supports this
hypothesis, indicating recombination sites close to genome
positions 200 and 3000, just upstream of the NS1 and VP1/2
ORFs. There are homologous regions in both these locations
which would facilitate such an event. Interestingly, recombination
events have been reported for NoV GII with the recombination
site similarly located in conserved sequence immediately upstream
of the capsid-encoding ORF [34]. Nevertheless, since there is less
than 95% genetic similarity for all putative ORFs including those
encoding non-structural proteins (NS1 and NP1), this is consistent
with both HBoV2 and HBoV3 being new species of bocavirus.
Very recently, Kapoor et al. [35] reported the presence of a
novel Bocavirus. An analysis of the sequence (FJ170280) confirms
their novel bocavirus is very similar (.99.7%) to HBoV2-W153,
indicating that the same virus has been simultaneously discovered
by two groups. Further, since they detected HBoV2 in samples
from children in Pakistan and Scotland, the combined reports
infer HBoV2 is globally distributed and likely to be commonly
associated with pediatric AGE in every community.
The family Parvoviridae are among the smallest viruses
measuring 18 to 26 nm, unenveloped, with an icosahedral capsid.
Their genomes are single, mostly negative-stranded linear DNA
between 2 and 6 kb in length [36]. Other parvoviruses, such as
canine parvovirus and feline panleukopenia virus, are associated
with gastroenteritis or enteric disease of their natural host [36] and
it was perhaps anomalous that to date there had not been a
parvovirus with a similar association in humans. In addition, other
parvoviruses are known to replicate only when the host cell is in S
phase, and results in the death of the host cell [36]. This would
suggest that virus shedding may peak later in the course of an
infection as any damaged and dead cells are replaced.
Our analysis of the prevalence and association with AGE is
based on samples from 186 age-matched case control pairs
collected during 2001 as part of a larger prospective study of over
600 cases and matched controls. In the univariant analysis of first
samples, only rotavirus infection was significantly associated with
AGE (Table 2). The inclusion of second samples collected within
three days of presentation for 105 cases resulted in significant
AGE-association for HBoV2, adenovirus and astrovirus, in
addition to rotavirus. It was only in the multivariate conditional
logistic regression analysis (Table 3) that NoV GII was associated
with AGE. Thus, although an association with AGE was not
achieved for HBoV2 in the most rigorous univariant analysis so
further conclusions require caution until additional data are
available, it is persuasive that an association with AGE was
achieved for HBoV2 in the same data analysis (pooled case
samples) in which significance was achieved for adenovirus and
NoV GII, the role of which as pathogens causing AGE is not
disputed [37]. HBoV2, at 17.2%, was the third most prevalent
virus after rotavirus (39.2%) and astrovirus (21.5%), and was
greater than that for NoV GII (13.4%) and adenovirus (4.8%).
Two further factors may be influencing the prevalence rates for
HBoV2 we have detected in both cases and controls. Firstly, S
phase synchronized replication observed for other parvoviruses
may also be applicable for HBoV2, in which case delayed and
perhaps cyclical or pulsed shedding of HBoV2 during infection
may result, consistent with our finding that 10 cases (31.2% of
positive cases) had detectable virus only in their second sample.
Therefore, the statistical association in the pooled sample data
may better reflect the true disease association. Secondly, long term
virus shedding post-infection, which is increasingly being recog-
nized for other enteric viruses such as NoV GII [38], may also
account for asymptomatic carriage among the controls. However,
until the natural history of HBoV2 infection is elucidated, the
influence of S phase replication and asymptomatic shedding can
only be speculative.
Although the data presented in Figure 4 suggests a close
relationship between strains within each bocavirus species, it was
evident from the failure of some primer pairs to amplify in the
nested reaction that sequence variation exists in our primer
binding sites. Further, while little trouble was experienced
recovering the near identical genomic sequence of HBoV2-
W208 using HBoV2-W153-derived primer sets, limited attempts
with the more variant HBoV2 and HBoV3 strains has proved
problematic. Therefore, sub-optimal primer binding may have led
to an under representation of HBoV2 and HBoV3 in our samples.
Indeed, Kapoor et al. [35] have recently reported a number of such
variants. Alternate primers to improve the broad reactivity of the
PCR assay, and real-time assays, are being investigated in a larger
series of cases.
Until a quantitative assay is available, the viral load in both
cases and controls cannot be assessed. However, a limited sample
dilution analysis with current assays, for which the sensitivity has
not been quantitatively assessed, have indicated viral loads range
from 100 to at least 10
11 DNA copies per gram of feces (data not
shown).
Although our original isolation of HBoV2 was from a sample
taken in the summer of 2001, screening of the 2001 sample set
indicated HBoV2 was detected throughout the year from summer
to early spring (Southern Hemisphere) with no obvious peak
incidence. It is interesting to note that most AGE infections in
Table 3. Conditional logistic regression of all viruses
associated with gastroenteritis with P value,0.2 in the
univariate analysis (Table 2, pooled samples from cases).
Virus Detected* P Value OR
{ (CI)
{
HBoV2 0.03 2.9 (1.1–7.7)
Rotavirus ,0.001 92.4 (12.2–702)
Astrovirus 0.008 3.6 (1.4–9.0)
Norovirus GII 0.006 4.1 (1.5–11.1)
Adenovirus 0.03 12.2 (1.3–111)
Norovirus GI 0.6 0.5 (0.05–5.7)
*Viruses detected from 186 cases and 186 age-matched paired controls in which
recognized bacterial pathogens were not detected.
{OR, odds ratio.
{CI, 95% confidence interval.
doi:10.1371/journal.ppat.1000391.t003
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(predominantly rotavirus and NoVII). Additional screening is
proceeding to assess if this distribution recurs annually.
Prevalence rates up to 8.6% have been reported for astrovirus
[15–17] but the analyses were largely retrospective and uncon-
trolled. The Danish case control study by Olesen et al. did not find
Figure 4. Maximum likelihood dendrogram (bootstrapped, 1,000 replicates) of HBoV, HBoV2, and HBoV3 partial NS1 sequences.
doi:10.1371/journal.ppat.1000391.g004
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low [7]. Dennehy et al. did report an association in a 5-year
prospective case control study in hospitalized young children [39]
but the analysis was flawed because controls were collected only
during one quarter of the enrolment period and over 75% of the
cases were unmatched. Thus our analysis confirming an
association between astrovirus and AGE (prevalence 21.5%,
P=0.01, odds ratio 2.4, 95% confidence interval 1.2–5.0) is the
first to do so in samples from matched case control pairs.
Recent reports have inferred HBoV may be associated with
diarrhea in children [25,26] but the studies were uncontrolled and
retrospective. Co-infection with another agent was common.
Further, when found in the stools of children with respiratory
disease, detection correlated to high respiratory viral load [24]. Our
analysis, which is the first to be based on fecal samples from
prospectively enrolled cases and controls, does not find a association
of HBoV with AGE. The lack of statistical association with
symptoms is consistent with the presence of HBoV in feces being
incidental, perhaps indicative of swallowed virus of respiratory
origin [24] or systemic spread as has been reported for B19
parvovirus [36]. A recent prospective study supports our finding by
detecting the asymptomatic acquisition of HBoV in respiratory
secretions of healthy children less than one year of age [40].
In conclusion, a prospective case controlled study into the causes
of AGE in children has identified a cluster of sporadic cases in
whom conventional viral and microbiological analysis has failed to
find a pathogen. Application of novel molecular testing techniques
has resulted in the identification of one novel virus, HBoV2 with
statistical data suggestive that it is causally associated with AGE and
a second novel virus, HBoV3, with as yet no disease association.
The detection of HBoV2 has reduced the pathogen-negative cases
by 17.5%. Although not a prime focus of the study, we have
additionally demonstrated a statistical association with AGE for
astrovirus, the first such study to do so with prospectively enrolled
matched case and control pairs. Lastly, we have similarly
demonstrated that HBoV is not statistically associated with AGE
and its presence in fecal samples is possibly the consequence of
swallowing respiratory secretions. There is evidence of further
genetic variation within strains which may be accounted for by
additional variant strains of HBoV2 or HBoV and perhaps other
bocaviruses. The role of HBoV3 in human disease is unknown.
Although detected equally in samples from cases and controls, the
prevalence is too low for meaningful analysis until further screening
for its presence in a variety of samples has been completed.
Further investigationof the association of HBoV2with AGE,and
the role of HBoV3 inhuman disease, is required.We are continuing
to test samples from over 600 cases and matched controls, and
sequence additional bocavirus strains to determine the extent of
sequence variation and to modify our screening assays accordingly.
Confirmation of the presence of HBoV2 in AGE cases elsewhere in
the world is needed as are further prospective controlled studies of
viral prevalence in AGE. HBoV2 may be associated with diseases
other than AGE and testing in other contexts will be needed.
Finally, despite the addition of HBoV2 to the list of proven and
probable causes of viral gastroenteritis, 25% of cases in this study
remain undiagnosed. Additional viral causes of gastroenteritis may
remain to be discovered.
Materials and Methods
Selection of faecal samples and screening for known
infectious agents
Stool samples analysed in this study were collected from January
to December 2001 from matched cases and controls who were
part of a larger case control study into the aetiology of sporadic
pediatric AGE. The study was approved by th je Research Ethics
Committees of the Women’s and Children’s Hospital (WCH) and
the Institute of Medical and Veterinary Science (IMVS). Following
informed patient/parent/guardian consent, prospective enrolment
was offered to patients presenting to the WCH in Adelaide, South
Australia, and meeting the case definition of three or more loose
stools within the last 24 hours, with or without vomiting, and a
duration prior to presentation of less than 7 days. Clinical histories
and parameters of disease progression were recorded for the
enrolled cases. One or two faecal samples were collected from
cases within 72 hours of enrolment but only a single sample from
controls. Samples were screened for bacteria (microscopy and
culture), parasites (microscopy) and viruses rotavirus and enteric
adenovirus by antigen capture immunoassay [41] and caliciviruses
and astrovirus by RT-PCR [17]. All PCR products were
confirmed by nucleic acid sequencing before being classed as
positive for the caliciviruses or astrovirus, see Table 1. In order to
limit costs, the prevalence of bacteria and parasites, which have
been previously assessed in prospective case control studies, was
determined for the cases only, where the cost of testing was met by
existing hospital pathology expenditure as part of patient
management. Age matched controls (within 3 months for patients
less than 6 months of age, within 9 months for patients 6 months to
2 years of age, within 12 months for 2 to 5 year old patients and
within 24 months for patients older than 5 years) without
symptoms of AGE were selected from patients and their siblings
presenting to hospital at a similar time (median 8 days, maximum
35 days) with non-diarrheal conditions such as respiratory
infections, asthma or surgical admissions. Insufficient controls
were available to permit sex matching. Samples from an apparent
cluster of undiagnosed sporadic AGE cases enrolled during the
summer of 2001 were chosen for the initial screening for the
presence of novel viruses since we hypothesised this may represent
an outbreak of a novel viral infectious agent even though we had
no epidemiological information to link the cases.
DOP method
Stored frozen (270uC) fecal samples were thawed and 0.5 ml of
a 10% suspension in phosphate buffered saline was prepared for
each and microfuged (13,000 rpm; 15 mins) to remove solids.
Each supernatant was filtered through a 0.2 nm bacterial filter,
digested with nucleases [30] and virions pelleted (28,000 rpm 2 hr,
Beckman Coulter, Beverly, USA) before extracting the remaining
viral nucleic acid fraction using the RNeasy Mini Kit system
(QIAGEN, Hilden, Germany) according to the manufacturer’s
instructions. Nucleic acids not examined immediately were stored
at 270uC. DOP PCR reactions were performed incorporating a
single DOP primer and biphasic PCR amplification cycles [29,32].
Briefly, the DOP 25-mer oligonucleotide primer consists of a 39
four base anchor region which binds to both strands of any nucleic
acid at approximately 250 base intervals. Adjacent to this is a six
base degenerate region that provides sufficient binding homology
to stabilize the primer binding at low annealing temperatures and
permit priming and amplification during the first cycling phase
which utilizes low annealing temperatures (30uC), slow tempera-
ture ramping and long extension times (5 minutes). In the initial
replication cycles, the DOP primer 59 tag region of 15 specific
bases does not participate in the binding, but as replication
proceeds, this sequence becomes incorporated at the termini of the
amplified product, increasing the homology of the DOP primer to
its target and therefore permitting the second cycling phase which
utilizes higher annealing temperatures (50uC) and fast temperature
ramping.
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mative, revealing only a DNA smear. To monitor amplification
efficiency, an adenovirus positive fecal sample was included in
each batch of samples being amplified. If a 10
4 or greater increase
in adenovirus genome copies was detected in this sample,
measured by a adenovirus-specific real-time PCR (unpublished),
then the DOP-amplified products from the remaining samples in
the batch were individually cloned without gel analysis into pCR
TopoTA 4.0 vector and transformed into One Shot Topo10
competent cells (Invitrogen, Paisley, UK) according to manufac-
turer’s instructions. Using sterile toothpicks, bacterial colonies
were picked directly into PCR mix (25 ml) containing 16
GeneAmp PCR buffer (Applied Biosystems Inc [ABI], Foster
City, USA), 2 mM MgCl2(ABI), 0.2 mM dNTPs (Finnzymes,
Espoo, Finland), 1.25 U AmpliTaq Gold (ABI), and M13 universal
forward and reverse primers (50 pmol each, Invitrogen) to amplify
the DNA inserts. PCR products were assessed by gel electropho-
resis and reactions containing single DOP amplicons of length
greater than 250 nucleotides were sequenced with BigDye 3
terminator chemistry (ABI) using an ABI 3730 sequencing
analyzer. Agencourt AMPure and Agencourt CleanSEQ (Beck-
man Coulter, Inc., Beverly, USA) were used to clean the PCR
products before and after the sequencing reactions, respectively.
Sequence analysis
DOP-generated sequence was screened for homology in
GenBank (NCBI, Bethesda, USA) using tBLASTx (translated
nucleotide versus translated nucleotide database) and BLASTn
(nucleotide vs nucleotide database) searches. Sequence analysis,
assembly of contiguous genome sequences, ORF analysis and
sequence alignments throughout the study were performed using
Kodon (Applied Maths, St-Martens-Latem, Belgium) incorporat-
ing the HBoV (strain st2, GenBank DQ000496) genome sequence
as a comparison during sequence assembly. Gaps in the HBoV2
sequence were spanned using primers designed to the DOP-
generated flanking sequences for PCR amplification from the
original fecal specimen and sequencing. Distal sequences were
generated using a semi-DOP approach whereby specific primers
facing out to the termini of the HBoV2 genome, and the DOP
primer, were used to amplify and sequence flanking DNA. The
genome sequence was then rederived using specific overlapping
primer sets spanning the genome to PCR amplify and sequence
the viral DNA directly from the index fecal specimen (W153).
Additional complete parvovirus sequences obtained from Gen-
Bank and used in the phylogenetic analyses (PAUP* 4, Sinauer
Associates, Sunderland, Massachusetts) were as follows;
NC_006148 snake parvovirus 1; NC_001701 goose parvovirus;
NC_006147 Muscovy duck parvovirus; AF043303, AF063497,
AF513851, AF513852, AF085716 Adeno-associated viruses;
AY622943 human parvovirus 4; U86868 Chipmunk parvovirus;
AF321230 Kilham rat virus; NC_001358 H-1 parvovirus;
NC_001510 and DQ196317 minute virus of mice; NC_001630
mouse parvovirus 1; NC_001539 canine parvovirus; EF988660
Feline panleukopenia virus; NC_001718 porcine parvovirus;
NC_001662 Aleutian mink disease parvovirus; AF221123 Pig-
tailed macaque parvovirus; U26342 Simian parvovirus;
NC_000883 human parvovirus B19; NC_006259 bovine parvo-
virus 2; DQ335247 and NC_001540 bovine parvovirus 1;
AB158475 minute virus of canines and human bocavirus strains:
St1 DQ000495; St2 DQ000496; WLL1 DQ778300; WLL2
EF441262; CU74 EF203922). The recently published sequence
of HBoV2 (FJ170280) was also used in genome similarity
comparisons.
Nested consensus diagnostic PCR
DNA was extracted from 100 ml of a 10% (vol/vol) fecal
specimen using the RNeasy Mini Kit system (QIAGEN) and
amplified using a modification of the ‘hanging drop’ nested PCR
method [17]. Current published primer sets to amplify HBoV
[25,26,31,32,42] do not contain sufficient homology to successfully
amplify products from HBoV2-W153. From an alignment of the
NS1 gene sequences from HBoV2-W153 and HBoVs (DQ000495
and DQ000496), several primers (Sigma-Genosys, Castle Hill,
Australia) targeting regions of shared sequence homology were
chosen to amplify both HBoV2 and HBoV sequence. The primers
were then tested in a variety of relevant combinations to ascertain
which primer pairs achieved the most sensitive amplification in a
nested PCR reaction, as measured by serial 10-fold dilutions of
W153. Extracted nucleic acid (2.5 ml) was added to the primary
amplification mix (25 ml) containing 16 GeneAmp PCR Buffer,
1.5 mM MgCl2, 0.2 mM of each dNTP 1.25 U AmpliTaq Gold
and 10 pmol each of the primers Adel-OF (AGGTAAAACAAA-
TATTGCAAAGGCCATAGTC) and Adel-OR (TGGGAGTT-
CTCTCCGTCCGTATC). The mix was overlaid with paraffin
oil. The secondary amplification mix (25 ul) containing 16
GeneAmp PCR Buffer, 5.5 mM MgCl2 (to yield 3.5 mM during
secondary amplification), 0.2 mM of each dNTP, 1.25 U
AmpliTaq Gold and 40 pmol each of the primers Adel-IF
(AGGGTTTGTCTTTAACGATTGCAGACAAC) and Adel-IR
(TATACACAGAGTCGTCAGCACTATGAG), was located in
the tube cap, to be suspended by surface tension during the
primary amplification cycles. After 15 min activation at 94uC, 40
cycles of amplification (94uC for 30 secs, 52uC for 30 secs, 72uC
for 1.5 min) were performed using an unheated lid. Once
completed, the tubes were microfuged briefly to introduce the
secondary amplification mix, and after 15 min activation at 94uC,
60 cycles of amplification as above, were performed. Several
negative samples were included in each batch to monitor for false
positive reactions resulting from contamination. Amplification
products were visualized using agarose gel electrophoresis for
products of the predicted size; primary amplification product,
732 bp, and secondary nested product 518 bp. Products of 590
and 659 bp may also be present, the result of amplification
between an outer and inner primer pair. Products of the predicted
size were sequenced using Big Dye 3 terminator chemistry (ABI) to
confirm the sequence identity. Sequence alignments, error
correction and similarity analysis (Maximum likelihood) were
performed using Kodon and PAUP* 4. Additional sequence
similarity analysis was performed with SimPlot 3.2 (S C. Ray,
Johns Hopkins University, Baltimore, MD) [43].
Statistical methods
A univariant analysis was performed on age-matched case and
control pairs using McNemar’s test for correlated proportions. A
multivariant matched analysis was performed using conditional
logistic regression. Calculations were carried out in VassarStats (R.
Lowry Vassarstats, http://faculty.vassar.edu/lowry/VassarStats.
html, Vassar College, Poughkeepsie, USA) and Stata version 9
(StataCorp, College Station, Texas).
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